Zacks: Brokerages Expect Diebold Nixdorf, Incorporated (NYSE:DBD) Will Post Earnings of -$0.22 Per Share

Wall Street analysts expect that Diebold Nixdorf, Incorporated (NYSE:DBDGet Rating) will announce earnings per share (EPS) of ($0.22) for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for Diebold Nixdorf’s earnings. The lowest EPS estimate is ($0.29) and the highest is ($0.14). Diebold Nixdorf reported earnings per share of $0.10 during the same quarter last year, which suggests a negative year-over-year growth rate of 320%. The business is expected to report its next quarterly earnings results on Monday, January 1st.

According to Zacks, analysts expect that Diebold Nixdorf will report full-year earnings of ($0.78) per share for the current year, with EPS estimates ranging from ($0.85) to ($0.71). For the next fiscal year, analysts forecast that the company will report earnings of $1.28 per share, with EPS estimates ranging from $0.85 to $1.70. Zacks Investment Research’s EPS averages are an average based on a survey of research firms that cover Diebold Nixdorf.

Diebold Nixdorf (NYSE:DBDGet Rating) last released its quarterly earnings data on Tuesday, May 10th. The technology company reported ($1.61) EPS for the quarter, missing analysts’ consensus estimates of ($0.22) by ($1.39). Diebold Nixdorf had a negative return on equity of 7.51% and a negative net margin of 6.69%. The firm had revenue of $829.80 million during the quarter, compared to analyst estimates of $914.75 million. During the same quarter in the prior year, the company posted $0.29 EPS. The company’s quarterly revenue was down 12.1% on a year-over-year basis.

DBD has been the subject of several research reports. Wedbush reaffirmed a “neutral” rating and issued a $10.00 target price on shares of Diebold Nixdorf in a research report on Thursday, May 5th. StockNews.com initiated coverage on Diebold Nixdorf in a research note on Thursday, March 31st. They issued a “hold” rating for the company. JPMorgan Chase & Co. lowered Diebold Nixdorf from an “overweight” rating to a “neutral” rating in a research note on Tuesday, May 10th. Zacks Investment Research lowered Diebold Nixdorf from a “hold” rating to a “sell” rating in a research report on Wednesday, April 13th. Finally, DA Davidson lowered their price objective on Diebold Nixdorf from $15.00 to $7.00 in a research report on Wednesday, April 27th.

In other Diebold Nixdorf news, CFO Jeffrey L. Rutherford acquired 19,413 shares of the company’s stock in a transaction that occurred on Thursday, May 12th. The stock was acquired at an average cost of $2.81 per share, for a total transaction of $54,550.53. Following the transaction, the chief financial officer now directly owns 432,556 shares in the company, valued at $1,215,482.36. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Octavio Marquez acquired 48,791 shares of the company’s stock in a transaction that occurred on Thursday, May 12th. The shares were acquired at an average price of $2.27 per share, with a total value of $110,755.57. Following the completion of the transaction, the chief executive officer now owns 325,719 shares in the company, valued at $739,382.13. The disclosure for this purchase can be found here. Insiders have purchased a total of 97,604 shares of company stock worth $235,866 over the last three months. 4.18% of the stock is owned by insiders.

Several hedge funds have recently made changes to their positions in DBD. Counterpoint Mutual Funds LLC purchased a new stake in Diebold Nixdorf during the fourth quarter valued at about $29,000. Huntington National Bank lifted its stake in Diebold Nixdorf by 56.0% in the fourth quarter. Huntington National Bank now owns 5,850 shares of the technology company’s stock worth $53,000 after acquiring an additional 2,100 shares during the period. Royal Bank of Canada lifted its stake in Diebold Nixdorf by 161.4% in the second quarter. Royal Bank of Canada now owns 5,426 shares of the technology company’s stock worth $69,000 after acquiring an additional 3,350 shares during the period. Everence Capital Management Inc. purchased a new position in Diebold Nixdorf during the first quarter valued at $95,000. Finally, Raymond James & Associates bought a new position in shares of Diebold Nixdorf during the first quarter valued at $103,000. 82.41% of the stock is owned by institutional investors.

Shares of DBD stock opened at $3.22 on Friday. Diebold Nixdorf has a 12 month low of $2.20 and a 12 month high of $14.95. The business’s 50 day moving average is $5.64 and its two-hundred day moving average is $7.79.

About Diebold Nixdorf (Get Rating)

Diebold Nixdorf, Incorporated provides connected commerce solutions to financial institutions and retailers in Western Europe, Eastern Europe, Asia, the Middle East, Africa, the United States, Canada, Mexico, and Latin America. It operates through Eurasia Banking, Americas Banking, and Retail segments.

See Also

Get a free copy of the Zacks research report on Diebold Nixdorf (DBD)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Diebold Nixdorf (NYSE:DBD)

Receive News & Ratings for Diebold Nixdorf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diebold Nixdorf and related companies with MarketBeat.com's FREE daily email newsletter.